Comprehensive Psychiatry
Volume 46, Issue 1 , Pages 6-13 , January 2005

The spectrum of substance use in mood and anxiety disorders

  • Alfredo Sbrana

      Affiliations

    • Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, 56127 Pisa, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 050 993401; fax: +39 050 992656.
    • ,
  • Jacopo Vittoriano Bizzarri

      Affiliations

    • Drug Addiction Service (Ser.T.), 39100 Bolzano, Italy
    • ,
  • Paola Rucci

      Affiliations

    • Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, 56127 Pisa, Italy
    • ,
  • Chiara Gonnelli

      Affiliations

    • Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, 56127 Pisa, Italy
    • ,
  • Maria Rosa Doria

      Affiliations

    • Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, 56127 Pisa, Italy
    • ,
  • Sabrina Spagnolli

      Affiliations

    • Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, 56127 Pisa, Italy
    • ,
  • Laura Ravani

      Affiliations

    • Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, 56127 Pisa, Italy
    • ,
  • Federica Raimondi

      Affiliations

    • Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, 56127 Pisa, Italy
    • ,
  • Lilliana Dell'Osso

      Affiliations

    • Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, 56127 Pisa, Italy
    • ,
  • Giovanni Battista Cassano

      Affiliations

    • Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, 56127 Pisa, Italy

References 

  1. Brooner RK, King Van L, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch. Gen. Psychiatry. 1997;54(1):71–80
  2. Cuffel BJ. Comorbid substance use disorder: prevalence, patterns of use, and course. New Dir. Ment. Health Serv. 1996;(70):93–105
  3. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511–2518
  4. Kessler RC, Nelson CB, Mcgonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R Major Depressive Disorder in the general population: results from the US National Comorbidity Survey. Br. J. Psychiatry. 1996;168(Suppl. 30):17–30
  5. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict. Behav. 1998;23(6):893–907
  6. Degenhardt L, Lynskey M, Coffey C, Patton G. ‘Diagnostic orphans’ among young adult cannabis users: persons who report dependence symptoms but do not meet diagnostic criteria. Drug Alcohol Depend. 2002;67(2):205–212
  7. Olfson M, Broadhead WE, Weissman MM, Leon AC, Farber L, Hoven C, et al. Subthreshold psychiatric symptoms in a primary care group practice. Arch. Gen. Psychiatry. 1996;53(10):880–886
  8. Cassano GB, Michelini S, Shear K, Coli E, Maser JD, Frank E. The panic-agoraphobic spectrum: a descriptive approach to the assessment and treatment of subtle symptoms. Am. J. Psychiatry. 1997;154(Suppl. 6):27–38[review]
  9. Cassano GB, Dell'Osso L, Frank E, Miniati M, Fagiolini A, Shear K, et al. The bipolar spectrum: a clinic reality in search of diagnostic criteria and assessment methodology. J. Affect. Disord. 1999;54(3):319–328
  10. Frank E, Shear MK, Rucci P, Cyranowski JM, Endicott J, Fagiolini A, et al. Influence of panic-agoraphobic spectrum symptoms on treatment response in recurrent major depression. Am. J. Psychiatry. 2000;157(7):1101–1107
  11. Sbrana A, Dell'Osso L, Gonnelli C, Impagnatiello P, Doria MR, Spagnolli S, et al. Acceptability, validity and reliability of the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS): a pilot study. Int. J. Methods Psychiatr. Res. 2003;12(2):105–115
  12. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependance. Am. J. Psychiatry. 1985;142(11):1259–1264[review]
  13. Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry. 1997;4(5):231–244[review]
  14. Pope HG. Drug abuse and psychopathology. N. Engl. J. Med. 1979;301(24):1341–1342
  15. Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of etiological theories. Addict. Behav. 1998;23(6):717–734
  16. Aharonovich E, Nguyen HT, Nunes EV. Anger and depressive states among treatment-seeking drug abusers: testing the psychopharmacological specificity hypothesis. Am. J. Addict. 2001;10(4):327–334
  17. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for the DSM-IV Axis I Disorders (SCID I/P, version 2). New York: Biometrics Research Department, New York State Psychiatric Institute; 1995;
  18. Rucci P, Frank E, Fagiolini A, Kupfer DJ, Shear MK, Dell'Osso L, et al. Development and preliminary testing of the General 5-Spectrum Measure (GSM-V). Depress. Anxiety. 2003;18(3):109–117
  19. Szuster RR, Pontius EB, Campos PE. Marijuana sensitivity and panic anxiety. J. Clin. Psychiatry. 1988;49:427–429
  20. Aronson TA, Craig TJ. Cocaine precipitation of panic disorder. Am. J. Psychiatry. 1986;143(5):643–645
  21. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord. 2001;3(4):181–188[review]
  22. Deacon BJ, Valentiner DP. Substance use and non-clinical panic attacks in a young adult sample. J. Subst. Abuse. 2001;11(1):7–15
  23. Page A, Andrews G. Do specific anxiety disorders show specific drug problems?. Aust. N. Z. J. Psychiatry. 1996;30:410–414
  24. Mirin S, Weiss R, Griffin M, Michael J. Psychopathology in drug abusers and their families. Compr. Psychiatry. 1991;32:36–51
  25. Markowitz JS, Weissman MM, Oullette R, Lish JD, Klerman GL. Quality of life in panic disorders. Arch. Gen. Psychiatry. 1989;46:984–992
  26. Katerndahl DA, Realini JP. Relationship between substance abuse and panic attacks. Addict. Behav. 1999;24(5):731–736
  27. Myrick H, Brady K. Editorial review: current review of the comorbidity of affective, anxiety and substance use disorders. Curr. Opin. Psychiatry. 2003;16(3):261–270
  28. Lyoo IK, Lee DW, Kim YS, Kong SW, Kwon JS. Patterns of temperament and character in subjects with obsessive-compulsive disorder. J. Clin. Psychiatry. 2001;62(8):637–641
  29. Moeller FG, Dougherty DM. Impulsivity and substance abuse: what is the connection?. Addict. Disord. Their Treat. 2002;1:3–10
  30. Lewinsohn PM, Solomon A, Seeley JR, Zeiss A. Clinical implications of “subthreshold” depressive symptoms. J. Abnorm. Psychol. 2000;109(2):345–351
  31. Abraham HD, Fava M. Order of onset of substance abuse and depression in a sample of depressed outpatients. Compr. Psychiatry. 1999;40(1):44–50
  32. Drake RE, Wallach MA, Alverson HS, Mueser KT. Psychosocial aspects of substance abuse by clients with severe mental illness. J. Nerv. Ment. Dis. 2002;190(2):100–106[review]
  33. Liraud F, Verdoux H. Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders?. Psychiatry Res. 2000;93(1):63–72

PII: S0010-440X(04)00105-1

doi: 10.1016/j.comppsych.2004.07.017

Comprehensive Psychiatry
Volume 46, Issue 1 , Pages 6-13 , January 2005

Article Tools

* Image Usage & Resolution